There is a cycle to cycle variation in ovarian response and pre-hCG serum progesterone level: an analysis of 244 consecutive IVF cycles
- PMID: 32978461
- PMCID: PMC7519678
- DOI: 10.1038/s41598-020-72597-0
There is a cycle to cycle variation in ovarian response and pre-hCG serum progesterone level: an analysis of 244 consecutive IVF cycles
Abstract
We aimed to answer one key question, that was not previously addressed as to whether serum progesterone (P4-hCG day) and its co-variates (estradiol (E2-hCG day) and the number of retrieved oocytes) of a given cycle can be predictive of the subsequent cycle when both cycles are consecutive and comparable for the stimulation protocol, gonadotropin dose and duration of stimulation. We analyzed such 244 consecutive (< 6 months) IVF cycles in 122 patients with GnRH agonist long protocol and found that P4, E2 and the number of retrieved oocytes significantly vary between the two cycles. Although P4 increased (ranging from 4.7 to 266.7%) in the 2nd cycle in 61 patients, E2 and the number of retrieved oocytes, which are normally positively correlated with P4 paradoxically decreased in the 41% and 37.7% respectively, of these same 61 patients. When a similar analysis was done in the 54 out of 122 patients (44.3%) in whom serum P4 was decreased in the 2nd cycle, the mean decrease in P4 was - 34.1 ± 23.3% ranging from - 5.26 to - 90.1%. E2 and the number of retrieved oocytes paradoxically increased in the 42.3% and 40.7% of these 54 patients respectively. P4 remained the same only in the 7 (5.7%) of these 122 patients. These findings indicate that late follicular phase serum P4 may change unpredictably in the subsequent IVF cycle. The changes are not always necessarily proportional with ovarian response of previous cycle suggesting that growth characteristics and steroidogenic activities of antral cohorts may exhibit considerable cycle to cycle variations.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles.Hum Reprod. 2019 Feb 1;34(2):345-355. doi: 10.1093/humrep/dey353. Hum Reprod. 2019. PMID: 30520979
-
Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.Hum Reprod. 2019 May 1;34(5):942-948. doi: 10.1093/humrep/dez023. Hum Reprod. 2019. PMID: 30927415 Clinical Trial.
-
Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.Hum Reprod. 2016 Aug;31(8):1859-65. doi: 10.1093/humrep/dew141. Epub 2016 Jun 14. Hum Reprod. 2016. PMID: 27301360
-
Ovarian stimulation for freeze-all IVF cycles: a systematic review.Hum Reprod Update. 2020 Jan 1;26(1):118-135. doi: 10.1093/humupd/dmz037. Hum Reprod Update. 2020. PMID: 31867625
-
Improving the luteal phase after ovarian stimulation: reviewing new options.Reprod Biomed Online. 2014 May;28(5):552-9. doi: 10.1016/j.rbmo.2014.01.012. Epub 2014 Feb 5. Reprod Biomed Online. 2014. PMID: 24656557 Review.
Cited by
-
GnRH agonist early follicular challenge test as a predictor of ovarian response in antagonist cycles for fertility preservation.Sci Rep. 2024 Jun 21;14(1):14308. doi: 10.1038/s41598-024-65059-4. Sci Rep. 2024. PMID: 38906914 Free PMC article.
-
Unraveling the Clinical FSH Conundrum: Insights From the Small Ovarian Reserve Heifer Model.Mol Reprod Dev. 2025 Feb;92(2):e70007. doi: 10.1002/mrd.70007. Mol Reprod Dev. 2025. PMID: 39935023 Free PMC article. Review.
-
"Short agonist stop" protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study.Front Endocrinol (Lausanne). 2022 Nov 17;13:1056520. doi: 10.3389/fendo.2022.1056520. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36465628 Free PMC article.
References
-
- Griesinger G, et al. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertil. Steril. 2013;100(1622–1628):e1621–1623. doi: 10.1016/j.fertnstert.2013.08.045. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources